share_log

利民股份(002734.SZ):当期百菌清原药市场供不应求

Limin Group (002734.SZ): During the current period, the market for the raw material of Bacillus thuringiensis is in short supply.

Gelonghui Finance ·  Nov 26 00:00

Gelonghui reported on November 26 that limin group (002734.SZ) stated on the investor interaction platform that the market for the original drug Baijunqing is in short supply, leading to price increases, while the prices of major raw materials remain stable. The company's subsidiary, Xinhahe, has a production capacity of 0.03 million tons per year, accounting for about 47% of the global capacity. Currently, the company's products are in a scheduled delivery status, and market demand and price expectations are optimistic.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment